Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT

[1]  P. Sugarbaker,et al.  Peritoneal Carcinomatosis: Principles of Management , 1996, Cancer Treatment and Research.

[2]  M. Ducreux,et al.  Peritoneal carcinomatosis of colorectal origin. , 2006, Gastroenterologie clinique et biologique.

[3]  A. S. Salmón,et al.  PET in abdominal pathology: advantages and limitations , 2006, Abdominal Imaging.

[4]  M. Pocard,et al.  Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma. , 2005, Gastroenterologie clinique et biologique.

[5]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Shimada,et al.  Value of 18F-FDG PET in the detection of peritoneal carcinomatosis , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  A. Witkamp,et al.  Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement , 2004, Journal of surgical oncology.

[8]  S. Larson,et al.  Peritoneal carcinomatosis: role of (18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  Y. Taki,et al.  Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. , 2002, American journal of surgery.

[10]  Rosalie J. Hagge,et al.  The Role of F-18 FDG Positron Emission Tomography in Preoperative Assessment of the Liver in Patients Being Considered for Curative Resection of Hepatic Metastases from Colorectal Cancer , 2002, Clinical nuclear medicine.

[11]  H. Hricak,et al.  Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. , 2002, Radiology.

[12]  J. Fleshman,et al.  Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum , 2000, Diseases of the colon and rectum.

[13]  P. Sugarbaker.  Management of peritoneal-surface malignancy: the surgeon’s role , 1999, Langenbeck's Archives of Surgery.

[14]  H. Tonami,et al.  Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  P. Sugarbaker,et al.  Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. , 1995, Journal of the American College of Surgeons.

[16]  K. Jablonski,et al.  Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.

[17]  P. Sugarbaker,et al.  Evaluation of computed tomography in patients with peritoneal carcinomatosis , 1993, Cancer.

[18]  N. Boyd,et al.  Computed Tomography in Advanced Ovarian Cancer: An Evaluation of Diagnostic Accuracy , 1987, The American journal of the medical sciences.

[19]  A Sánchez Salmón,et al.  PET in abdominal pathology: advantages and limitations. , 2006, Abdominal imaging.

[20]  L. Oñate-Ocaña,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement , 2006, Annals of Surgical Oncology.